SJ

Satish Jindal

General Partner at Advent Life Sciences

Cambridge, Massachusetts

Overview

Work Experience

AL

Advent Life Sciences

  • General Partner

    2022 - Current

    Through partnership with BioMotiv

Antolrx Pharmaceuticals

  • Board Member and Co-founder

    2014 - 2022

B

BioMotiv

  • CEO

    2019 - 2021

ET

Elicio Therapeutics

  • Co-Founder/Founding CEO

    2010 - 2019

BS

Bristol-Myers Squibb

  • Vice President, BMS;

    2011 - 2014

Verastem, Inc ( VSTM)

  • President/COO; Co-founder

    2009 - 2011

NeoGenesis Pharmaceuticals (acquired by Schering Plough)

  • CEO, Founder, Chairman, BoD

    1997 - 2005

PerSeptive Biosystems, Inc.

  • Senior Director

    1995 - 1996

Education

Investments

Amphista Therapeutics

Series A

Total Funding: $61M

Relevant Websites